Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Vivo Disease”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Early research (Phase 1)Study completedNCT00891137
What this trial is testing

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+2 more
Cellerant Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT03181399
What this trial is testing

Diet Treatment Glucose Transporter Type 1 Deficiency (G1D)

Who this might be right for
GLUT1DS1EpilepsyGlut1 Deficiency Syndrome 1, Autosomal Recessive+4 more
University of Texas Southwestern Medical Center 45
Early research (Phase 1)Study completedNCT02018315
What this trial is testing

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

Who this might be right for
Glucose Transporter Type 1 Deficiency SyndromeGLUT1 Deficiency Syndrome
Juan Pascual 14
Large-scale testing (Phase 3)Ended earlyNCT02960217
What this trial is testing

Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 44
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Testing effectiveness (Phase 2)Ended earlyNCT00555048
What this trial is testing

Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaMyelodysplastic Syndromes+1 more
Fred Hutchinson Cancer Center 1
Not applicableTemporarily pausedNCT04137692
What this trial is testing

Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type 1 Deficiency SyndromeGLUT1DS1
Weill Medical College of Cornell University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07432490
What this trial is testing

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Who this might be right for
Glut1 DeficiencyGLUT1DS1
Oregon Health and Science University 16
Early research (Phase 1)Study completedNCT03158896
What this trial is testing

Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease

Who this might be right for
Acute Graft Versus Host Disease
University of Kansas Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT02036853
What this trial is testing

An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS)
Adrian Lacy 20
Early research (Phase 1)UnknownNCT00004036
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDrug/Agent Toxicity by Tissue/OrganLeukemia+5 more
The Cleveland Clinic 30
Not applicableStudy completedNCT04399954
What this trial is testing

Evaluation of Ketoflo

Who this might be right for
Epilepsy IntractableGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting
Vitaflo International, Ltd 25
Not applicableStudy completedNCT04332289
What this trial is testing

Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.

Who this might be right for
Bariatric SurgeryHypoglycemiaGastric Bypass
Lia Bally 4
Not applicableLooking for participantsNCT05085704
What this trial is testing

Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

Who this might be right for
Glut1 Deficiency Syndrome 1Glucose Metabolism DisordersEpilepsy+4 more
Weill Medical College of Cornell University 20
Not applicableStudy completedNCT01483989
What this trial is testing

In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients

Who this might be right for
Dry Eye Syndrome
Alcon Research 19
Testing effectiveness (Phase 2)Study completedNCT01819350
What this trial is testing

In Vivo Study of Sucrose and Liquid Oral Pediatric Medicines of Long-term Effect on Dental Biofilm pH

Who this might be right for
Dental Biofilm pH
Federal University of Paraíba 12
Not applicableStudy completedNCT02915211
What this trial is testing

Evaluation of Keyo in Children With Epilepsy

Who this might be right for
Intractable EpilepsyGlucose Transporter Type 1 Deficiency SyndromeKetogenic Dieting
Vitaflo International, Ltd 17
Testing effectiveness (Phase 2)UnknownNCT02000960
What this trial is testing

Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome
University of British Columbia 3
Testing effectiveness (Phase 2)Ended earlyNCT02599961
What this trial is testing

Study to Assess the Long Term Safety and Efficacy of UX007 in Participants With Glucose Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome
Ultragenyx Pharmaceutical Inc 15
Testing effectiveness (Phase 2)Study completedNCT01993186
What this trial is testing

Phase 2 Study of Triheptanoin (UX007) for the Treatment of Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)

Who this might be right for
Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Ultragenyx Pharmaceutical Inc 36
Load More Results